about
Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model.Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis.Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.Icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway.Inflammation, not Cholesterol, Is a Cause of Chronic Disease.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging targets for combination therapy in melanomas.
@en
type
label
Emerging targets for combination therapy in melanomas.
@en
prefLabel
Emerging targets for combination therapy in melanomas.
@en
P2093
P2860
P1433
P1476
Emerging targets for combination therapy in melanomas.
@en
P2093
Mayara D'Auria Jacomassi
Renata de Freitas Saito
Roger Chammas
Tharcísio Citrângulo Tortelli
P2860
P304
P356
10.1016/J.FEBSLET.2015.09.022
P407
P577
2015-10-05T00:00:00Z